PFG Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.17M | Sell |
|
|||||
|
2024
Q4 | $1.81M | Sell |
|
|||||
|
2024
Q3 | $8.97M | Buy |
|
|||||
|
2024
Q2 | $7.26M | Buy |
|
|||||
|
2024
Q1 | $6.96M | Buy |
|
|||||
|
2023
Q4 | $374K | Buy |
|
|||||
|
2023
Q3 | $301K | Buy |
|
|||||
|
2023
Q2 | $340K | Sell |
|
|||||
|
2023
Q1 | $467K | Sell |
|
|||||
|
2022
Q4 | $535K | Sell |
|
|||||
|
2022
Q3 | $513K | Buy |
|
|||||
|
2022
Q2 | $471K | Buy |
|
|||||
|
2022
Q1 | $524K | Buy |
|
|||||
|
2021
Q4 | $620K | Sell |
|
|||||
|
2021
Q3 | $759K | Buy |
|
|||||
|
2021
Q2 | $708K | Buy |
|
|||||
|
2021
Q1 | $599K | Buy |
|
|||||
|
2020
Q4 | $539K | Buy |
|
|||||
|
2020
Q3 | $441K | Buy |
|